Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash, cash equivalents and federal funds sold | 10.90%862.1M | 10.90%862.1M | 8.77%777.4M | 8.77%777.4M | 75.56%714.7M | 75.56%714.7M | -34.24%407.1M | --407.1M | --619.1M |
| -Cash and cash equivalents | 10.90%862.1M | 10.90%862.1M | 8.77%777.4M | 8.77%777.4M | 75.56%714.7M | 75.56%714.7M | -34.24%407.1M | --407.1M | --619.1M |
| Securities and investments | 0.30%1.61B | 0.30%1.61B | -33.74%1.61B | -33.74%1.61B | -13.18%2.43B | -13.18%2.43B | -14.29%2.79B | --2.79B | --3.26B |
| -Short term investments | 0.30%1.61B | 0.30%1.61B | -33.74%1.61B | -33.74%1.61B | -13.18%2.43B | -13.18%2.43B | -14.29%2.79B | --2.79B | --3.26B |
| Derivative assets | -88.89%300K | -88.89%300K | -73.00%2.7M | -73.00%2.7M | -48.19%10M | -48.19%10M | 505.97%19.3M | --19.3M | --3.19M |
| Net loan | 16.15%12.33B | 16.15%12.33B | 19.96%10.62B | 19.96%10.62B | 45.84%8.85B | 45.84%8.85B | 74.31%6.07B | --6.07B | --3.48B |
| -Gross loan | 16.15%12.33B | 16.15%12.33B | 19.96%10.62B | 19.96%10.62B | 45.84%8.85B | 45.84%8.85B | 74.31%6.07B | --6.07B | --3.48B |
| Net PPE | -18.60%7M | -18.60%7M | 10.26%8.6M | 10.26%8.6M | 90.24%7.8M | 90.24%7.8M | -3.28%4.1M | --4.1M | --4.24M |
| -Gross PPE | -4.20%11.4M | -4.20%11.4M | 25.26%11.9M | 25.26%11.9M | 25.00%9.5M | 25.00%9.5M | 79.29%7.6M | --7.6M | --4.24M |
| -Accumulated depreciation | -33.33%-4.4M | -33.33%-4.4M | -94.12%-3.3M | -94.12%-3.3M | 51.43%-1.7M | 51.43%-1.7M | ---3.5M | ---3.5M | ---- |
| Goodwill and other intangible assets | -1.24%47.7M | -1.24%47.7M | 26.11%48.3M | 26.11%48.3M | 60.92%38.3M | 60.92%38.3M | 48.58%23.8M | --23.8M | --16.02M |
| -Other intangible assets | -1.24%47.7M | -1.24%47.7M | 26.11%48.3M | 26.11%48.3M | 60.92%38.3M | 60.92%38.3M | 48.58%23.8M | --23.8M | --16.02M |
| Deferred assets | -11.71%62.6M | -11.71%62.6M | 10.95%70.9M | 10.95%70.9M | 12.90%63.9M | 12.90%63.9M | 33.60%56.6M | --56.6M | --42.37M |
| Other assets | -16.10%52.1M | -16.10%52.1M | 59.64%62.1M | 59.64%62.1M | -2.51%38.9M | -2.51%38.9M | 10.48%39.9M | --39.9M | --36.11M |
| Total assets | 13.50%14.98B | 13.50%14.98B | 8.60%13.2B | 8.60%13.2B | 29.07%12.15B | 29.07%12.15B | 26.15%9.41B | --9.41B | --7.46B |
| Liabilities | |||||||||
| Total deposits | 20.09%9.88B | 20.09%9.88B | 38.16%8.23B | 38.16%8.23B | 45.57%5.95B | 45.57%5.95B | 60.56%4.09B | --4.09B | --2.55B |
| Current debt and capital lease obligation | -0.89%3.12B | -0.89%3.12B | -30.33%3.15B | -30.33%3.15B | 17.80%4.52B | 17.80%4.52B | 8.59%3.83B | --3.83B | --3.53B |
| -Current debt | -0.89%3.12B | -0.89%3.12B | -30.33%3.15B | -30.33%3.15B | 17.80%4.52B | 17.80%4.52B | 8.59%3.83B | --3.83B | --3.53B |
| Derivative product liabilities | 57.89%6M | 57.89%6M | -60.82%3.8M | -60.82%3.8M | 31.08%9.7M | 31.08%9.7M | --7.4M | --7.4M | ---- |
| Payables | 14.13%197.1M | 14.13%197.1M | 64.32%172.7M | 64.32%172.7M | 184.05%105.1M | 184.05%105.1M | 112.72%37M | --37M | --17.39M |
| -Accounts payable | -19.50%12.8M | -19.50%12.8M | 28.23%15.9M | 28.23%15.9M | 7.83%12.4M | 7.83%12.4M | -33.89%11.5M | --11.5M | --17.39M |
| -Other payable | 17.54%184.3M | 17.54%184.3M | 69.15%156.8M | 69.15%156.8M | 263.53%92.7M | 263.53%92.7M | --25.5M | --25.5M | ---- |
| Current provisions | 11.02%64.5M | 11.02%64.5M | 16.67%58.1M | 16.67%58.1M | 55.14%49.8M | 55.14%49.8M | 756.23%32.1M | --32.1M | --3.75M |
| Current deferred liabilities | --2.9M | --2.9M | ---- | ---- | --18.5M | --18.5M | ---- | ---- | ---- |
| Employee benefits | -0.88%22.6M | -0.88%22.6M | 16.92%22.8M | 16.92%22.8M | 140.74%19.5M | 140.74%19.5M | --8.1M | --8.1M | ---- |
| Total liabilities | 14.27%13.29B | 14.27%13.29B | 8.96%11.63B | 8.96%11.63B | 33.27%10.67B | 33.27%10.67B | 31.30%8.01B | --8.01B | --6.1B |
| Shareholders'equity | |||||||||
| Share capital | 0.93%1.54B | 0.93%1.54B | 0.25%1.52B | 0.25%1.52B | 0.01%1.52B | 0.01%1.52B | 0.22%1.52B | --1.52B | --1.51B |
| -common stock | 0.93%1.54B | 0.93%1.54B | 0.25%1.52B | 0.25%1.52B | 0.01%1.52B | 0.01%1.52B | 0.22%1.52B | --1.52B | --1.51B |
| Retained earnings | 139.35%148.4M | 139.35%148.4M | 884.81%62M | 884.81%62M | 90.28%-7.9M | 90.28%-7.9M | 10.33%-81.3M | ---81.3M | ---90.66M |
| Gains losses not affecting retained earnings | 110.11%1.9M | 110.11%1.9M | 43.54%-18.8M | 43.54%-18.8M | -3.10%-33.3M | -3.10%-33.3M | 47.53%-32.3M | ---32.3M | ---61.56M |
| Total stockholders'equity | 7.75%1.69B | 7.75%1.69B | 5.97%1.57B | 5.97%1.57B | 5.16%1.48B | 5.16%1.48B | 3.08%1.4B | --1.4B | --1.36B |
| Total equity | 7.75%1.69B | 7.75%1.69B | 5.97%1.57B | 5.97%1.57B | 5.16%1.48B | 5.16%1.48B | 3.08%1.4B | --1.4B | --1.36B |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |